# David F. Stroncek

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-f-stroncek/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,667 |
| Field | CAR-T cell therapy research |
| h-index | 71 |
| i10-index | 304 |
| Last Known Institution | National Institutes of Health |
| OpenAlex ID | https://openalex.org/A5072166479 |
| ORCID iD | https://orcid.org/0000-0001-5867-3265 |
| Works | 656 |

## Researcher papers

- [CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy](https://scholariq.org/papers/cd22-targeted-car-t-cells-induce-remission-in-b-all-that-is-naive-or-resistant/)
- [CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial](https://scholariq.org/papers/cd4-cd8-t-cell-selection-affects-chimeric-antigen-receptor-car-t-cell-potency/)
- [Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL](https://scholariq.org/papers/long-term-follow-up-of-cd19-car-t-cell-therapy-in-children-and-young-adults-with/)

## Researcher topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Blood groups and transfusion](https://scholariq.org/topics/blood-groups-and-transfusion/)

## Researcher university

- [National Institutes of Health](https://scholariq.org/institutions/national-institutes-of-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.